Kardium reports strong PFA system trial results
Canada-based Kardium has revealed positive one-year efficacy results on its pulsed field ablation (PFA) device, the Globe PF system, at …
Post
-
-
Abbott reports new data from study of PFA system for atrial fibrillation
Abbott has reported new data from its prospective, non-randomised Volt CE Mark Study, indicating that individuals treated with pulsed field …
-
Medtronic’s defibrillation lead gains FDA approval for use in right ventricle
The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the …
-
HeartBeam partners with AccurKardia to enhance cardiac care
HeartBeam has announced a partnership with electrocardiogram (ECG)-based diagnostics software company AccurKardia, aimed at improving cardiac monitoring solutions’ accessibility. The alliance …
-
Roche’s diagnostic sales hit by China pricing reforms
Roche posted flat diagnostics sales in Q1 2025, impacted by recent healthcare pricing reforms in China. The big pharma company’s sales …
-
Boston Scientific reports outcomes from Farapulse and Farapoint trial
Boston Scientific has reported positive 12-month primary endpoint outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse pulsed …
-
Medtronic to distribute Dragonfly Endoscopy’s pancreaticobiliary system in US
Medtronic has signed an agreement for the distribution of Dragonfly Endoscopy’s pancreaticobiliary system in the US. The agreement’s financial terms remain …
-
Thermo Fisher counters tariffs with $2bn investment into US manufacturing
Thermo Fisher has outlaid $2bn to expand manufacturing and development in the US, joining the long list of companies directing …
-
GHIT Fund grants $4.5m to Fluxus for tuberculosis urine test development
The Global Health Innovative Technology (GHIT) Fund has awarded a $4.5m grant to US-based diagnostic developer Fluxus, a Fujirebio subsidiary, …
-
Intuitive warns of escalating tariff impact through 2025, despite strong Q1
Intuitive Surgical reported a strong Q1 but cautioned that future tariffs could have an “adverse impact” on its 2025 financial …
-
Roche introduces algorithm for ACS detection in individuals with chest pain
Roche has introduced its Chest Pain Triage algorithm, designed to rapidly identify acute coronary syndrome (ACS). This algorithm, part of the …
-
BD’s umbilical hernia patch secures FDA 510(k) clearance
Becton, Dickinson and Company (BD) has received the US Food and Drug Administration’s (FDA) 510(k) clearance for the Phasix ST …
-
Synthetic hormones and the future of contraception
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying …
-
Epiminder’s implantable EEG system for epilepsy receives FDA authorisation
Australia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous …
-
Intravascular lithotripsy: Reducing the risk of heart attacks and strokes
Heart disease remains one of the leading causes of mortality worldwide, with the World Health Organization estimating that it causes …
